Rafael Santana

Prof. Rafael Santana

UNAM FACMED

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JBJorge Luis Bermudez-Gonzalez
Jorge Luis Bermudez-Gonzalez
DQDenya Sánchez Quintero
Denya Sánchez Quintero
LPLeonardo Proaño-Bernal
Leonardo Proaño-Bernal
RSRafael Santana
Rafael Santana
MJMarco Antonio Jimenez-Chavarria
Marco Antonio Jimenez-Chavarria
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
Ischemia-reperfusion injury is a common problem in the age of interventional cardiology; it is primarily mediated by oxidative stress and reactive agents. Melatonin has antioxidative properties that make its use promising for treating ischemia-reperfusion injury. Multiple experimental studies in murine and porcine models have been performed with good results. Clinical trials have also been conducted but given their heterogeneity, no conclusive results can be made. Melatonin pharmacokinetic properties are not ideal; therefore, many analogs have been proposed with improved characteristics, and some studies have evaluated their efficacy in animal models, but clinical trials are needed to recommend their use. In this review, we expose the results of the most impactful studies regarding melatonin use in ischemia-reperfusion injury.